跳至主要内容
临床试验/NCT04897204
NCT04897204Unknown不适用

A Prospective Randomized Controlled Study of Additonal Left Atrial Appendage Electrical Isolation in Catheter Ablation Combined With Left Atrial Appendage Occlusion of Persistent Atrial Fibrillation

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine0 个研究点目标入组 120 人开始时间: 2021年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
120
主要终点
Atrial fibrillation recurrence

研究概览

简要总结

This project intends to enroll patients with persistent atrial fibrillation who are planning to undergo catheter ablation of atrial fibrillation. The two groups of patients were routinely performed atrial fibrillation pulmonary vein isolation and linear ablation with left atrial appendage occlusion. The experimental group received additional left atrial appendage electrical isolation before the left atrial appendage occlusion, and the control group did not perform left atrial appendage electrical isolation. We are intend to evaluate the safety and effectiveness of one-stop operation of left atrial appendage electrical isolation combined with left atrial appendage occlusion in the treatment of persistent atrial fibrillation.

详细描述

This project intends to enroll patients with persistent atrial fibrillation who are planned to undergo atrial fibrillation catheter ablation and left atrial appendage closure surgery, and randomly allocate them to the experimental group and the control group at a ratio of 1:1. The two groups of patients were routinely performed atrial fibrillation pulmonary vein isolation and linear ablation with left atrial appendage occlusion. The experimental group received additional left atrial appendage electrical isolation before the left atrial appendage occlusion, and the control group did not perform left atrial appendage electrical isolation. Follow-up for 1 year, compare the differences in the recurrence rate of atrial fibrillation between the two groups of patients, and further compare the differences in clinical events such as stroke, systemic embolism, hospitalization due to heart failure, and cardiovascular death.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18-85 years old;
  • •Symptomatic, non-valvular persistent atrial fibrillation (atrial fibrillation duration ≥ 1 week), and is ineffective to one or more anti-arrhythmic drugs;
  • •CHA2DS2-VASc score ≥ 2 points;
  • •The patient is ready to undergo atrial fibrillation catheter ablation and left atrial appendage closure surgery;
  • •Provide an informed consent form that is willing to participate in the research, follow-up trials and evaluation procedures.

排除标准

  • •Past left atrial appendage occlusion, atrial fibrillation catheter ablation or surgical ablation history;
  • •There are plans for cardiac surgery within 90 days;
  • •Stroke/transient ischemic attack occurred within 30 days;
  • •Have had atrial septal defect repair or have an ASD/PFO occluder in the body;
  • •Heart failure NYHA heart function grade IV;
  • •Combined with other serious diseases, the life expectancy is less than 2 years;
  • •Within 6 months after cardiac revascularization or other cardiac surgery;
  • •Women who are pregnant, breastfeeding, planning to become pregnant, or women of childbearing age who have not adopted reliable contraceptive methods;
  • •Obviously abnormal liver and kidney function and coagulation function;

研究组 & 干预措施

Left Atrial Appendage Electrical Isolation with One-stop treatment of atrial fibrillation

Experimental

The patients received routine catheter ablation of atrial fibrillation with left atrial appendage occlusion and additional left atrial appendage electrical isolation operation.

干预措施: Additional left atrial appendage electrical isolation combined with catheter ablation and left atrial appendage occlusion (Procedure)

One-stop treatment of atrial fibrillation

Other

The patients received routine catheter ablation of atrial fibrillation with left atrial appendage occlusion.

干预措施: Catheter ablation and left atrial appendage occlusion (Procedure)

结局指标

主要结局

Atrial fibrillation recurrence

时间窗: one year after operation

outside the 3-month blank period after surgery, ECG and Holter recorded rapid atrial arrhythmia greater than 30S.

Stroke/TIA

时间窗: one year after operation

Patients may have cerebral ischemia, such as sudden limb movement and sensory disturbance, aphasia, transient blindness in one eye, etc., disturbance of consciousness, or symptoms of vertebral artery ischemia, such as vertigo, tinnitus, hearing impairment, diplopia, Unsteady gait and difficulty swallowing, etc., patients may have obvious infarcts in the brain, which can be confirmed clinically by CT or MRI.

Hospitalization rate due to heart failure

时间窗: one year after operation

During the follow-up period, patients need hospitalization for heart failure, including acute heart failure, acute exacerbation of chronic heart failure, etc., which can be combined with clinical symptoms, signs, biochemical examinations (such as NT-proBNP) and cardiac ultrasound Wait for a clear diagnosis.

Cardiovascular death

时间窗: one year after operation

The death of a patient due to cardiac structure, function, coronary artery disease, and arrhythmia can be diagnosed in combination with clinical practice.

Systemic embolism

时间窗: one year after operation

The clinical manifestations or evidence of embolism in the blood vessels of the system, including renal artery, splenic artery, mesenteric artery, etc. during the follow-up of the patient, and relevant examinations can be used to confirm the diagnosis.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验